Intranasal esketamine: real-world clinical practice in treatment-resistant depression and factors associated with treatment response.

BMC Psychiatry March 17, 2026 Peer reviewed DOI: 10.1186/s12888-026-07980-8 via PubMed Central

Relevant Not relevant

Abstract

Intranasal esketamine: real-world clinical practice in treatment-resistant depression and factors associated with treatment response.

Sex- and Age-Stratified Differences in Antidepressant Response to Intranasal Esketamine in Treatment-Resistant Depression: A Secondary Analysis of the REAL-ESK Study Clinical Neuropsychopharmacology and Addiction • June 25, 2026 • via OpenAlex

Comments

No comments yet.

Log in to comment